A

Arecor Therapeutics PLC
LSE:AREC

Watchlist Manager
Arecor Therapeutics PLC
LSE:AREC
Watchlist
Price: 78 GBX 5.41%
Market Cap: 29.5m GBX

Wall Street
Price Targets

AREC Price Targets Summary
Arecor Therapeutics PLC

Wall Street analysts forecast AREC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AREC is 259.59 GBX with a low forecast of 253.51 GBX and a high forecast of 270.9 GBX.

Lowest
Price Target
253.51 GBX
225% Upside
Average
Price Target
259.59 GBX
233% Upside
Highest
Price Target
270.9 GBX
247% Upside
Arecor Therapeutics PLC Competitors:
Price Targets
TIL
Instil Bio Inc
794% Upside
JSPR
Jasper Therapeutics Inc
665% Upside
QTTB
Homology Medicines Inc
248% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
28% Upside
AMRN
Amarin Corporation PLC
26% Downside
ALCLS
Cellectis SA
61% Upside
ACAD
ACADIA Pharmaceuticals Inc
9% Upside
CDNA
CareDx Inc
27% Upside

Revenue
Forecast

Revenue Estimate
Arecor Therapeutics PLC

For the last 7 years the compound annual growth rate for Arecor Therapeutics PLC's revenue is 21%. The projected CAGR for the next 3 years is -44%.

21%
Past Growth
-44%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Arecor Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Arecor Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AREC's stock price target?
Price Target
259.59 GBX

According to Wall Street analysts, the average 1-year price target for AREC is 259.59 GBX with a low forecast of 253.51 GBX and a high forecast of 270.9 GBX.

What is Arecor Therapeutics PLC's Revenue forecast?
Projected CAGR
-44%

For the last 7 years the compound annual growth rate for Arecor Therapeutics PLC's revenue is 21%. The projected CAGR for the next 3 years is -44%.

Back to Top